The oncolytic virotherapy treatment platform for cancer: Unique biological and biosafety points to consider
Year: 2002
Type: review
Source: Cancer Gene Therapy
Authors: Richard Vile, Dale Ando, David Kirn
Institutions: Mayo Clinic, Genesys (United States), University of Oxford
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2125980219
